Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoledronic Acid for Bone Loss After Total Hip Arthroplasty
NCT01267279Phase 4Completed
- Sponsor
- Spokane Joint Replacement Center
- Start
- Jan 2005
- Primary completion
- Dec 2014
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of zoledronic acid in osteoporosis, sponsored by Spokane Joint Replacement Center. Started Jan 2005; status: completed.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01267279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01267279.